Cost-Effectiveness of a Household Salt Substitution Intervention: Findings From 20 995 Participants of the Salt Substitute and Stroke Study
Ka‐Chun Li(The George Institute for Global Health), Lei Si(Camden and Campbelltown Hospitals), Nicole Li(George Institute for Global Health), Liping Huang(UNSW Sydney), Darwin R. Labarthe(UK Health Forum), Yi Zhao(Ningxia Medical University), Paul Elliott(Ipsen (France)), Yangfeng Wu(Beijing Haidian Hospital), Maoyi Tian(Harbin Medical University), Yishu Liu(Peking University), Thomas Lung(The University of Sydney), Lijing L. Yan(Duke University), Gian Luca Di Tanna(University of Bern), Bo Zhou, Bruce Neal(UNSW Sydney), Ruijuan Zhang(China Women's University), Yuhong Zhang(Central Hospital of Zibo), Xinyi Zhang(Shenyang Agricultural University), Jianxin Zhang(Hebei Provincial Center for Disease Control and Prevention), Zhifang Li(Changzhi Medical College), Yan Yu(Xi'an Jiaotong University), Xiangxian Feng(Changzhi Medical College), Jixin Sun(Hebei Provincial Center for Disease Control and Prevention), Xuejun Yin(George Institute for Global Health), Zhixin Hao(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie Yu(Yangtze University)
Cited by 50
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k